Skip to content

PHARMA GUILLAUME

Active
Private limited companyfounded 2016active for 10 yearsRue Edouard Dinot 32, 5590 Ciney, Belgium13 active companies are registered at this addressKBO/BCE: BE 0656.563.207
Summary

PHARMA GUILLAUME has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €221,676 and a net result of €80,331. Equity is growing by about 45% per year across the filed financial years. Its solvency ranks better than 20% of 12,724 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).

Risk analysisFollow ReportCompare
PHARMA GUILLAUMEActiveChecked score 67/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
≈ €1.7mturnover 2025, estimated
Staff
2.6 FTE
Equity
€221,676
Profit
€80,331
Turnover estimated from the gross margin
Financial health
67 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.0%
Structure
Auditor: Callens, Vandelanotte & Theunissen SRL2025 accounts filed 26 days late3 of 7 deeds summarised
Why 67raises riskEquity €221,676 (9.4% of total assets)1 change of registered office in 24 monthslowers riskFigures for financial year 2025 (filed 27-08-2026)Size: 2.6 FTE, total assets €2.4mShow the evidence

Checked score

Score 2025
67 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 55% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 34+3
equity 9.4% of total assets
Liquidity 49=
short-term debt 30.7% · cash 9.5%
Profitability 73-1
return on assets 3.4%
Bankruptcy probability, 12 months
1.0% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,263 companies, NACE 47, micro)
Last 24 months 11-2024: 0.8% 12-2024: 0.8%● unchanged vs 11-2024 01-2025: 0.8%● unchanged vs 12-2024 02-2025: 0.8%● unchanged vs 01-2025 03-2025: 0.9%▲ +0.1 percentage points vs 02-2025 04-2025: 1.0%▲ +0.1 percentage points vs 03-2025 05-2025: 1.0%● unchanged vs 04-2025 06-2025: 1.2%▲ +0.2 percentage points vs 05-2025 07-2025: 1.4%▲ +0.2 percentage points vs 06-2025 08-2025: 1.9%▲ +0.5 percentage points vs 07-2025 09-2025: 2.5%▲ +0.6 percentage points vs 08-2025highest value 10-2025: 0.7%▼ -1.8 percentage points vs 09-2025 11-2025: 0.7%● unchanged vs 10-2025lowest value 12-2025: 0.7%● unchanged vs 11-2025lowest value 01-2026: 0.7%● unchanged vs 12-2025lowest value 02-2026: 0.7%● unchanged vs 01-2026 03-2026: 0.8%▲ +0.1 percentage points vs 02-2026 04-2026: 0.9%▲ +0.1 percentage points vs 03-2026 05-2026: 0.9%● unchanged vs 04-2026 06-2026: 1.1%▲ +0.2 percentage points vs 05-2026 07-2026: 1.2%▲ +0.1 percentage points vs 06-2026 08-2026: 1.8%▲ +0.6 percentage points vs 07-2026 09-2026: 1.0%▼ -0.8 percentage points vs 08-2026 10-2026: 1.0%● unchanged vs 09-2026
Credit of up to €14,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.73, compared with 0.7 in 2024, below 1; short-term debt: 30.7% and cash: 9.5% of total assets), and 90.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 26% on solvency, 49% on liquidity, 57% on profitability and 87% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · Equity €221,676 (9.4% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 27-08-2026)
NBB · annual accounts
lowers risk · Size: 2.6 FTE, total assets €2.4m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 12724 sector peers (2025).
NBB · sector comparison
Position among 12724 sector peers
Solvency
better than 20%
← weakest strongest →
raises risk · 2025 accounts filed 26 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-08-2026, 26 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
26 days late
2024
29 days late
2023
27 days late
2022
61 days early
2021
25 days late
2020
23 days late
2019
19 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 13 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. RestructuringMerger · Accounting effect ·…
  2. Annual accounts filedfinancial year 2025 · abbreviated…
  3. Resignation: Michel GUILLAUME (director)Appointments: Régis LANOVE, Thibault DEHAES…

Key points

  • Positive: Equity rose in 2025from €141,345 to €221,676 ▲ 56.8% View
  • Board changedlatest change 05-08-2026 · 2 in office 2 joined · 1 left View
  • Positive: 6 profitable years in a rowprofit 2025: €80,331 6 years View

By topic

Financials

Financial year
2025
Total assets
€2.4m
Profit
€80,331
Solvency
9.4%
Total assets▼ 5.4%
Net result
20182025
Go to Financials

Board & ownership

Board
2 members
Auditor
Callens, Vandelanotte & Theunissen…
  • Régis LanoveDirector
  • Thibault DEHAESDirector
Go to Board & ownership

Timeline

Events
17
Since
2017
Next accounts
by 31-07-2027
  1. 31-12-2025Equity above €200,000
  2. 29-08-2025Annual accounts filed
  3. 31-12-2024Highest result from 2018 to 2025
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
10-06-2016
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
26
Annual meeting
Last Saturday of May at 18:00
Purpose
“L'exploitation et la gestion d'officine(s) de pharmacie; Toutes opérations se rapportant…” (deed in French)
Go to Articles of association

Key facts about PHARMA GUILLAUME

What is the company number of PHARMA GUILLAUME?
0656.563.207. In Belgium the VAT number is the company number with BE in front: BE 0656.563.207.
Where is PHARMA GUILLAUME based?
The registered office is at Rue Edouard Dinot 32, 5590 Ciney.Company details
What does PHARMA GUILLAUME do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMA GUILLAUME?
Private limited company (BV).
When was PHARMA GUILLAUME founded?
On 10-06-2016.
Is PHARMA GUILLAUME still active?
Yes, PHARMA GUILLAUME is an active enterprise in the KBO register.
How many employees does PHARMA GUILLAUME have?
On average 2.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMA GUILLAUME?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is PHARMA GUILLAUME profitable?
In financial year 2025, PHARMA GUILLAUME made a profit of €80,331.
Where can I find the annual accounts of PHARMA GUILLAUME?
PHARMA GUILLAUME filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMA GUILLAUME due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to PHARMA GUILLAUME

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure